US equities
|
MU
$1,086.87
▲+3.95%
NVDA
$237.08
▼-0.90%
SNDK
$1,700.26
▲+2.40%
SPCX
$167.84
▼-2.37%
AMD
$645.83
▼-0.55%
TSLA
$377.06
▼-0.95%
INTC
$113.46
▲+0.85%
AAPL
$336.24
▲+0.78%
MU
$1,086.87
▲+3.95%
NVDA
$237.08
▼-0.90%
SNDK
$1,700.26
▲+2.40%
SPCX
$167.84
▼-2.37%
AMD
$645.83
▼-0.55%
TSLA
$377.06
▼-0.95%
INTC
$113.46
▲+0.85%
AAPL
$336.24
▲+0.78%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Bruce Halpryn
Recent news which mentions Bruce Halpryn
CincyTech-backed Eikonoklastes Therapeutics receives FDA approval for first-in-class ALS treatment
November 09, 2022
Tickers
INNO
Tags
Insurance
Bruce Halpryn
Mark Dato
From
Business Journals